Medicines losing patent protection

MonthYear

July 2027

2 medicines lose their last listed patent or exclusivity in July 2027.

Jul 5Pristiqdesvenlafaxine succinate · PF Prism CV
Jul 8Halaveneribulin mesylate · Eisai Inc

Dates are the patent and exclusivity end dates listed in the FDA's Orange Book, in its data up to October 9, 2026. Patents can be extended, challenged in court or settled, so a generic may come earlier, later or not at all. This is not legal or medical advice.

About the data·Privacy·Credits